Preimplantation Genetic Diagnosis (PGD or PGT-M)
In cases of patients carrying genes responsible for genetic diseases Preimplantation Genetic Diagnosis (PGD) can be utilized so that only disease-free embryos will be transferred during IVF.
Preimplantation Genetic Screening (PGS or PGT-A)
Used in conjunction with in vitro fertilization it enables genetic diagnosis in embryos resulting from IVF, to determine if there are numerical or structural chromosomal abnormalities. PGS may help treat cases of implantation failure, early pregnancy loss and advanced maternal age.
Patients who can benefit from PGD/PGS are:
➤ Couples that have one of the two members carrying a balanced chromosomal translocation
➤ Women over 38 years old with an increased risk of chromosomal arithmetic abnormalities
➤ Couples with a history of multiple miscarriages and / or previous abnormal pregnancies
➤ Patients with infertility and / or failed IVF
➤ Couples - carriers of single-gene diseases (dominant or residual) such as Mediterranean anemia, fibrotic disease, colon cancer etc. Couples with a history of sexually transmitted disease such as Duchenne, haemophilia etc.
➤ Couples with an already afflicted child wishing for the birth of another healthy and compatible child with the afflicted baby The embryo lab of the IVFclinic in Greece , blastocyst biopsy (5th day embryo) is performed with the most modern method that ensures the safety of the embryos and the best diagnosis for achieving pregnancy.